UBS Group’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-226
| Closed | -$8.24K | – | 10439 |
|
|
2024
Q2 | $8.24K | Buy |
+226
| New | +$8.15K | ﹤0.01% | 7809 |
|
|
2024
Q1 | – | Sell |
-1,088
| Closed | -$39.5K | – | 10257 |
|
|
2023
Q4 | $39.5K | Buy |
1,088
+803
| +282% | +$24K | ﹤0.01% | 6678 |
|
|
2023
Q3 | $8.58K | Buy |
285
+48
| +20% | +$1.61K | ﹤0.01% | 7179 |
|
|
2023
Q2 | $8.52K | Sell |
237
-2,093
| -90% | -$75K | ﹤0.01% | 7233 |
|
|
2023
Q1 | $77.4K | Buy |
2,330
+1,366
| +142% | +$47.5K | ﹤0.01% | 6123 |
|
|
2022
Q4 | $32.4K | Sell |
964
-451
| -32% | -$15.2K | ﹤0.01% | 7158 |
|
|
2022
Q3 | $49K | Buy |
1,415
+840
| +146% | +$30.5K | ﹤0.01% | 6378 |
|
|
2022
Q2 | $19K | Sell |
575
-3,264
| -85% | -$109K | ﹤0.01% | 6959 |
|
|
2022
Q1 | $152K | Buy |
3,839
+2,447
| +176% | +$96.7K | ﹤0.01% | 5584 |
|
|
2021
Q4 | $66K | Buy |
+1,392
| New | +$71.8K | ﹤0.01% | 6677 |
|
|
2020
Q2 | – | Sell |
-180
| Closed | -$6K | – | 8460 |
|
|
2020
Q1 | $6K | Sell |
180
-177
| -50% | -$6.46K | ﹤0.01% | 7247 |
|
|
2019
Q4 | $14K | Buy |
357
+43
| +14% | +$1.51K | ﹤0.01% | 7110 |
|
|
2019
Q3 | $10K | Buy |
314
+90
| +40% | +$2.99K | ﹤0.01% | 7179 |
|
|
2019
Q2 | $8K | Sell |
224
-165
| -42% | -$5.45K | ﹤0.01% | 7211 |
|
|
2019
Q1 | $14K | Buy |
389
+131
| +51% | +$4.35K | ﹤0.01% | 6605 |
|
|
2018
Q4 | $7K | Buy |
258
+133
| +106% | +$4.16K | ﹤0.01% | 7433 |
|
|
2018
Q3 | $5K | Sell |
125
-60
| -32% | -$2.18K | ﹤0.01% | 7518 |
|
|
2018
Q2 | $6K | Buy |
185
+140
| +311% | +$4.71K | ﹤0.01% | 7425 |
|
|
2018
Q1 | $1K | Buy |
45
+35
| +350% | +$1.16K | ﹤0.01% | 7680 |
|
|
2017
Q4 | $0 | Buy |
+10
| New | +$304 | ﹤0.01% | 8163 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$5K | – | 8068 |
|
|
2016
Q4 | $5K | Buy |
+200
| New | +$4.89K | ﹤0.01% | 7265 |
|
UBS Group's BTEC Position: Q3 2024 in Review
UBS Group sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 226 shares — an estimated $8.24K sold.
UBS Group first reported a position in BTEC in Q4 2016 and held it in 21 quarters. The position peaked at $152K in Q1 2022. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- UBS Group reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- UBS Group sold 226 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $8.24K.
- UBS Group first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2016 and held it in 21 quarters.
- UBS Group's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $152K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.